GO:0035312 5'-3' DNA exonuclease activity: Mechanism, Genes and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0035312 (5'-3' DNA exonuclease activity) describes the catalysis of sequential cleavage of mononucleotides from a free 5' terminus of a DNA molecule, as defined by QuickGO.
This activity is a molecular_function that removes nucleotides processively in the 5' to 3' direction, distinct from 3'-5' proofreading exonucleases [3,4,6].
Key experimental models include bacteriophage T5 5'-3' exonuclease, Thermus aquaticus DNA polymerase I, and Bst DNA polymerase I, which have been used to characterize the activity [3,4,6].
The 5'-3' exonuclease activity is critical for DNA end resection during homologous recombination, as shown for BRCA1-BARD1.
Phospholipase D3 (PLD3) exhibits 5'-3' exonuclease activity that degrades mitochondrial DNA, linking this activity to nucleotide signaling and APP metabolism.
Researchers study this activity using biochemical assays, CRISPR knockout models, and structural approaches to understand its roles in DNA repair and disease [1,3,5].

Description

GO:0035312, 5'-3' DNA exonuclease activity, is a molecular function defined by the Gene Ontology as the catalysis of the sequential cleavage of mononucleotides from a free 5' terminus of a DNA molecule. This activity is essential for processing DNA ends during replication, repair, and recombination, and it is mechanistically distinct from 3'-5' exonucleases that proofread DNA synthesis [3,4,6]. The enzyme removes nucleotides one by one from the 5' end, generating a free 3' hydroxyl group that can be used for subsequent DNA synthesis or ligation. This activity has been characterized in diverse systems, including bacteriophage T5, where the 5'-3' exonuclease exhibits structure-specific DNA binding, and in Thermus aquaticus DNA polymerase I, where inactivation of the 5'-3' exonuclease domain affects DNA processing. In eukaryotic cells, the 5'-3' exonuclease activity is central to DNA end resection, a key step in homologous recombination, as demonstrated for the BRCA1-BARD1 complex. Additionally, phospholipase D3 (PLD3) has been shown to possess 5'-3' exonuclease activity that degrades mitochondrial DNA, influencing nucleotide signaling and amyloid precursor protein metabolism. Understanding this activity is therefore crucial for researchers studying DNA repair, genome stability, and related diseases.

5'-3' DNA exonuclease activity At A Glance

GO ID GO:0035312
GO term 5'-3' DNA exonuclease activity
Ontology molecular_function
Synonym 5'-3' exodeoxyribonuclease activity
Major function Sequential cleavage of mononucleotides from a free 5' terminus of DNA
Directionality 5' to 3'
Substrate DNA
Products Mononucleotides and a shortened DNA strand
Related activity 3'-5' exonuclease activity (proofreading)

What Is GO:0035312?

5'-3' DNA exonuclease activity (GO:0035312) is the catalytic function of sequentially removing mononucleotides from the 5' end of a DNA strand. It requires a free 5' terminus and proceeds in the 5' to 3' direction, releasing individual nucleotides. This activity is distinct from 3'-5' exonuclease activity, which degrades DNA from the 3' end and is often associated with proofreading during DNA replication. The term is synonymous with 5'-3' exodeoxyribonuclease activity and is classified as a molecular_function in the Gene Ontology.

Why Is 5'-3' DNA exonuclease activity Important in Cell Biology?

5'-3' DNA exonuclease activity is fundamental to DNA metabolism, playing critical roles in DNA repair, recombination, and replication. It is required for DNA end resection during homologous recombination, a process essential for accurate repair of double-strand breaks. Defects in this activity can lead to genomic instability and are implicated in cancer and neurodegenerative diseases [1,5]. The activity also contributes to mitochondrial DNA degradation and nucleotide signaling, linking it to metabolic and neurodegenerative pathways. Understanding its mechanism and regulation is therefore vital for developing therapeutic strategies and for interpreting experimental models in gene editing research.
Enables DNA end resection during homologous recombination, a key step in double-strand break repair.
Contributes to processing of Okazaki fragments during DNA replication, although the exact role may vary by organism.
Plays a role in mitochondrial DNA degradation and nucleotide signaling, as shown for PLD3.
Distinct from 3'-5' proofreading exonucleases, which are involved in replication fidelity.
Can be studied using thermostable DNA polymerases such as Taq and Bst, which possess or lack this activity [4,6].
Its inactivation in Taq DNA polymerase affects DNA processing and has implications for molecular biology applications.
Structure-specific DNA binding by bacteriophage T5 5'-3' exonuclease provides insights into substrate recognition.
Dysregulation of 5'-3' exonuclease activity may contribute to cancer and neurodegeneration [1,5].
CRISPR-based models allow precise interrogation of genes encoding 5'-3' exonucleases.
Biochemical assays and structural studies are essential for characterizing this activity.

What Happens During 5'-3' DNA exonuclease activity?

Substrate Recognition and Binding
In simple terms: The enzyme first finds and binds to the end of a DNA strand.
The 5'-3' exonuclease must recognize a free 5' terminus on DNA. Bacteriophage T5 5'-3' exonuclease exhibits structure-specific DNA binding, preferentially interacting with certain DNA structures such as flaps or forks. This binding is a prerequisite for catalysis and ensures that the enzyme acts on appropriate substrates. In the context of homologous recombination, the BRCA1-BARD1 complex promotes DNA end resection by recognizing and processing DNA ends.
Sequential Cleavage of Mononucleotides
In simple terms: The enzyme cuts off one nucleotide at a time from the 5' end.
Once bound, the enzyme catalyzes the sequential removal of mononucleotides from the 5' terminus. This process is processive, meaning the enzyme remains attached to the DNA and continues cleaving multiple nucleotides. The reaction releases individual mononucleotides and leaves a shortened DNA strand with a new 5' terminus. This activity has been demonstrated for Thermus aquaticus DNA polymerase I, where the 5'-3' exonuclease domain is responsible for removing nucleotides during DNA synthesis.
Role in DNA End Resection
In simple terms: This activity helps create long single-stranded DNA tails needed for repair.
During homologous recombination, 5'-3' exonuclease activity is part of the DNA end resection machinery that generates 3' single-stranded DNA overhangs. BRCA1-BARD1 promotes this resection, and its dysfunction leads to defective repair. This step is crucial for the subsequent invasion of the homologous template and accurate repair.
Mitochondrial DNA Degradation
In simple terms: The enzyme can also break down DNA in mitochondria.
Phospholipase D3 (PLD3) possesses 5'-3' exonuclease activity that degrades mitochondrial DNA. This degradation regulates nucleotide signaling and impacts amyloid precursor protein metabolism, linking the activity to mitochondrial quality control and neurodegeneration.

Key Genes Involved in GO:0035312 5'-3' DNA exonuclease activity

The following genes and proteins are directly associated with 5'-3' DNA exonuclease activity, as supported by published literature.
GeneMajor RoleResearch Relevance
BRCA1Promotes DNA end resection in homologous recombinationBreast and ovarian cancer; DNA repair studies
BARD1Partners with BRCA1 to promote resectionCancer susceptibility; homologous recombination
PLD3Exhibits 5'-3' exonuclease activity on mitochondrial DNANeurodegeneration; APP metabolism
Taq DNA polymerase IContains 5'-3' exonuclease domainMolecular biology; PCR; DNA processing
Bst DNA polymerase ILacks 3'-5' proofreading but has 5'-3' exonucleaseIsothermal amplification; strand displacement
Bacteriophage T5 5'-3' exonucleaseStructure-specific DNA binding and cleavageModel for exonuclease mechanism
DNA polymerase I (E. coli)Prototype for 5'-3' exonuclease activityHistorical model for DNA replication and repair
FEN1Flap endonuclease with 5'-3' exonuclease activityOkazaki fragment processing; cancer
EXO15'-3' exonuclease involved in resectionDNA repair; cancer
MRE11Has 3'-5' exonuclease and endonuclease activitiesDNA damage response; ataxia-telangiectasia-like disorder
RAD51Recombinase that binds single-stranded DNA generated by resectionHomologous recombination; cancer
CtIPPromotes end resection with MRN complexDNA repair; cancer
BLMHelicase that facilitates resectionBloom syndrome; genome stability
DNA2Helicase-nuclease involved in resectionDNA repair; mitochondrial maintenance
EXD23'-5' exonuclease involved in resectionDNA repair; genome stability
WRNHelicase-exonuclease involved in replication and repairWerner syndrome; cancer
APEX2Has 3'-5' exonuclease and AP endonuclease activitiesBase excision repair; cancer

How Is 5'-3' DNA exonuclease activity Regulated?

The regulation of 5'-3' DNA exonuclease activity occurs at multiple levels. In homologous recombination, the activity is tightly controlled by post-translational modifications and protein-protein interactions. For example, BRCA1-BARD1 promotes DNA end resection, and its activity is regulated by phosphorylation and ubiquitination. PLD3-mediated mitochondrial DNA degradation may be influenced by cellular stress and metabolic signals. Additionally, the expression and activity of exonucleases such as FEN1 and EXO1 are cell-cycle regulated to ensure proper DNA replication and repair. However, specific regulatory mechanisms for many 5'-3' exonucleases remain to be fully elucidated.

5'-3' DNA exonuclease activity and Human Disease

GeneDisease / BiologyPotential Experimental Model
BRCA1Breast and ovarian cancer; defective DNA repairKnockout or point mutation in cell lines; xenograft models
BARD1Cancer susceptibility; homologous recombinationKnockout or knockdown in cancer cell lines
PLD3Alzheimer's disease; mitochondrial dysfunctionKnockout or overexpression in neuronal cells
EXO1Cancer; DNA repair deficiencyKnockout in cancer cell lines; mouse models
FEN1Cancer; Okazaki fragment processing defectsKnockout or point mutation in cell lines
Cancer and Genomic Instability
Defects in 5'-3' DNA exonuclease activity can lead to impaired DNA end resection and homologous recombination, resulting in genomic instability and cancer predisposition. BRCA1 and BARD1 mutations, which affect resection, are strongly associated with breast and ovarian cancers. Other exonucleases like EXO1 and FEN1 are also implicated in cancer when their functions are altered.
Neurodegeneration
PLD3, which possesses 5'-3' exonuclease activity, has been linked to Alzheimer's disease through its role in mitochondrial DNA degradation and amyloid precursor protein metabolism. Dysregulation of this activity may contribute to neuronal dysfunction and neurodegeneration.
Mitochondrial Disorders
The degradation of mitochondrial DNA by 5'-3' exonucleases such as PLD3 is important for mitochondrial quality control. Imbalances in this process can affect nucleotide signaling and mitochondrial function, potentially contributing to mitochondrial diseases.

From 5'-3' DNA exonuclease activity-Related Genes to Experimental Models

Research QuestionSuitable Model
Does knockout of BRCA1 affect 5'-3' exonuclease activity?CRISPR knockout of BRCA1 in HeLa or U2OS cells
How does a point mutation in PLD3 affect its exonuclease activity?CRISPR point mutation knock-in in SH-SY5Y cells
Can we tag endogenous EXO1 to study its localization?Knock-in of fluorescent tag at EXO1 locus
What is the effect of overexpressing Taq DNA polymerase I?Overexpression in E. coli or mammalian cells
Does FEN1 knockout alter DNA repair efficiency?CRISPR knockout in HAP1 cells
Can we screen for genes regulating 5'-3' exonuclease activity?CRISPR library screening with reporter assays

How to Study the 5'-3' DNA exonuclease activity Process

MethodWhat It MeasuresTypical Application
In vitro exonuclease assayEnzymatic activity and kineticsCharacterization of purified exonucleases
Electrophoretic mobility shift assay (EMSA)DNA binding affinity and specificityStudying structure-specific binding
CRISPR knockoutLoss-of-function effects on activityIdentifying gene requirements
CRISPR point mutationEffect of specific amino acid changesDissecting catalytic residues
Knock-in taggingProtein localization and interactionsLive-cell imaging
OverexpressionGain-of-function effectsDominant-negative or hyperactive studies
CRISPR library screeningGenome-wide identification of regulatorsUnbiased discovery of pathway components
Biochemical Exonuclease Assays
In vitro exonuclease assays using radiolabeled or fluorescently labeled DNA substrates are used to measure 5'-3' exonuclease activity. These assays can determine substrate specificity, processivity, and kinetic parameters. For example, the activity of Taq DNA polymerase I and its mutants has been characterized using such assays.
Structural Biology
X-ray crystallography and cryo-EM can reveal the atomic structure of exonucleases bound to DNA, providing insights into substrate recognition and catalysis. The structure-specific DNA binding of bacteriophage T5 5'-3' exonuclease has been studied to understand its mechanism.
CRISPR-Based Genetic Screens
CRISPR knockout or activation screens can identify genes that regulate or are required for 5'-3' exonuclease activity. These screens often use reporter systems that detect DNA repair or resection events. Such approaches can uncover novel components of the resection machinery.
Live-Cell Imaging
Fluorescently tagged exonucleases or DNA repair proteins can be imaged in live cells to study their recruitment to DNA damage sites and their dynamics. This method helps link the activity to specific cellular processes in real time.

How CRISPR Can Be Used to Study GO:0035312 5'-3' DNA exonuclease activity

Knockout

CRISPR knockout of genes encoding 5'-3' exonucleases, such as BRCA1, BARD1, or PLD3, allows researchers to assess their contribution to DNA repair, mitochondrial function, and disease phenotypes. Knockout cell lines can be used in functional assays to measure exonuclease activity and downstream effects [1,5].

Point Mutation

Introducing specific point mutations in the catalytic domain of a 5'-3' exonuclease can abolish or alter its activity, enabling structure-function studies. For example, mutating the active-site residues of Taq DNA polymerase I can inactivate its 5'-3' exonuclease activity.

Knock-in

Knock-in of epitope tags or fluorescent proteins at endogenous loci allows for precise tracking of exonuclease expression, localization, and interactions. This approach is valuable for studying the spatiotemporal dynamics of 5'-3' exonuclease activity in cells.

Overexpression

Overexpression of wild-type or mutant 5'-3' exonucleases can reveal gain-of-function phenotypes, such as increased resection or mitochondrial DNA degradation. This strategy is useful for testing whether elevated activity contributes to disease.

How EDITGENE Supports 5'-3' DNA exonuclease activity Research

Researchers studying 5'-3' DNA exonuclease activity-related genes often need to determine whether a candidate gene is causally involved in DNA repair, mitochondrial function, or disease. EDITGENE provides a comprehensive suite of CRISPR services to enable precise genetic modifications in relevant cell models.
Contact EDITGENE today to design your custom CRISPR model for 5'-3' DNA exonuclease activity research.

Frequently Asked Questions About 5'-3' DNA exonuclease activity

It is the catalytic function of sequentially removing mononucleotides from the 5' end of a DNA molecule, as defined by GO:0035312 [3,4].
Genes include BRCA1, BARD1, PLD3, EXO1, FEN1, and DNA polymerases such as Taq and Bst [1,4,5,6].
5'-3' exonucleases cleave from the 5' end, while 3'-5' exonucleases cleave from the 3' end and often function in proofreading.
It is essential for DNA end resection during homologous recombination, generating 3' single-stranded DNA overhangs for repair.
Defects are linked to cancer (e.g., BRCA1 mutations) and neurodegeneration (e.g., PLD3 in Alzheimer's disease) [1,5].
Common methods include in vitro exonuclease assays, CRISPR knockout/knock-in models, and structural biology [3,4].
The substrate is DNA with a free 5' terminus, and the enzyme releases mononucleotides.
Yes, the enzyme typically remains bound and cleaves multiple nucleotides sequentially [3,4].
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools for dissecting gene function [1,5].
EDITGENE provides custom knockout, point mutation, knock-in, and overexpression cell lines for relevant genes [1,5].

Conclusion

5'-3' DNA exonuclease activity (GO:0035312) is a fundamental molecular function that removes nucleotides from the 5' end of DNA, playing critical roles in DNA repair, recombination, and mitochondrial maintenance. Its dysregulation is linked to cancer and neurodegeneration, making it a key target for research. By leveraging CRISPR-based models and biochemical assays, researchers can uncover the precise mechanisms and disease relevance of this activity. EDITGENE offers comprehensive services to support these investigations.

References

  1. 1. Salunkhe S et al.. 2024. Promotion of DNA end resection by BRCA1-BARD1 in homologous recombination.. Nature 634(8033):482-491 PMID: 39261729
  2. 3. Garforth SJ et al.. 1997. Structure-specific DNA binding by bacteriophage T5 5'-->3' exonuclease.. Nucleic Acids Res 25(19):3801-7 PMID: 9380501
  3. 4. Merkens LS et al.. 1995. Inactivation of the 5'-3' exonuclease of Thermus aquaticus DNA polymerase.. Biochim Biophys Acta 1264(2):243-8 PMID: 7495870
  4. 5. Van Acker ZP et al.. 2023. Phospholipase D3 degrades mitochondrial DNA to regulate nucleotide signaling and APP metabolism.. Nat Commun 14(1):2847 PMID: 37225734
  5. 6. Aliotta JM et al.. 1996. Thermostable Bst DNA polymerase I lacks a 3'-->5' proofreading exonuclease activity.. Genet Anal 12(5-6):185-95 PMID: 8740835
Contact Us
*
*
*
*
How did you hear about us: